Intracerebral accumulation of neurotoxic dicarboxylic acids (DCAs) plays an important pathophysiological role in glutaric aciduria type I and methylmalonic aciduria. Therefore, we investigated the transport characteristics of accumulating DCAs -glutaric (GA), 3-hydroxyglutaric (3-OH-GA) and methylmalonic acid (MMA) -across porcine brain capillary endothelial cells (pBCEC) and human choroid plexus epithelial cells (hCPEC) representing in vitro models of the blood-brain barrier (BBB) and the choroid plexus respectively. We identified expression of organic acid transporters 1 (OAT1) and 3 (OAT3) in pBCEC on mRNA and protein level. For DCAs tested, transport from the basolateral to the apical site (i.e. efflux) was higher than influx. Efflux transport of GA, 3-OH-GA, and MMA across pBCEC was Na + -dependent, ATP-independent, and was inhibited by the OAT substrates para-aminohippuric acid (PAH), estrone sulfate, and taurocholate, and the OAT inhibitor probenecid. Members of the ATP-binding cassette transporter family or the organic anion transporting polypeptide family, namely MRP2, P-gp, BCRP, and OATP1B3, did not mediate transport of GA, 3-OH-GA or MMA confirming the specificity of efflux transport via OATs. In hCPEC, cellular import of GA was dependent on Na + -gradient, inhibited by NaCN, and unaffected by probenecid suggesting a Na + -dependent DCA transporter. Specific transport of GA across hCPEC, however, was not found. In conclusion, our results indicate a low but specific efflux transport for GA, 3-OH-GA, and MMA across pBCEC, an in vitro model of the BBB, via OAT1 and OAT3 but not across hCPEC, an in vitro model of the choroid plexus.
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Introduction
Accumulation of characteristic neurotoxic dicarboxylic acids (DCAs) is the common biochemical hallmark of glutaric aciduria type I (GA-I; MIM # 231670) and methylmalonic aciduria (MMAuria; MIM # 251000, 277400, 251100, 277410, 251110, 277380, and 606169), two inherited organic acidurias. GA-I is an autosomal recessive defect of glutaryl-coenzyme A (CoA) dehydrogenase (GCDH, EC 1.3.99.7), a central enzyme in the distal catabolic pathways of L-lysine, L-tryptophan, and L-hydroxylysine catalyzing the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO 2 . GCDH expression has been demonstrated in brain, liver and kidney with the highest activity in the latter two tissues [1, 2] . The clinical presentation of untreated patients is characterized by the onset of acute striatal injury during encephalopathic crises. These crises are precipitated by episodes that are likely to induce catabolic state such as intercurrent febrile illnesses during a vulnerable period of brain development in infancy [3, 4] . Affected patients display elevated levels of glutaric acid (GA) and 3-hydroxyglutaric acid (3-OH-GA) in serum and urine. Post
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MMAuria is an etiologically heterogeneous group of metabolic disorders caused by inherited deficiency of the mitochondrial enzyme methylmalonyl-CoA mutase (MCM; EC 5.4.99.2) or by defects in the uptake, transport, or synthesis of its cofactor 5′-deoxyadenosylcobalamin. MCM catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA linking the final degradative pathways of branched-chain amino acids, odd number fatty acids, and the cholesterol side chain to the tricarboxylic acid cycle. MCM is also present in the brain, whereas highest tissue-specific MCM activity is found in liver and kidneys [6] . The disease course is characterized by acute metabolic crises during catabolic state that can result in multiple-organ failure or even death. Major long-term complications are severe neurological deficits, chronic renal failure, cardiomyopathy, and pancreatitis [7, 8] . Among them, neurological symptoms such as extrapyramidal movement disorders, psychomotor retardation and epileptic seizures are most frequently found [9] . Biochemically, MMAuria is characterized by the accumulation of the name-giving DCA methylmalonic acid (MMA), metabolites deriving from alternative oxidation pathways of propionyl-CoA, such as 3-hydroxypropionic acid and 2-methylcitric acid, as well as the glycine and carnitine conjugates propionylglycine and -carnitine [10] .
Cerebral impairment in GA-I and MMAuria is currently understood to be induced by synergistic intracellular and extracellular toxic effects of accumulating organic acids and CoA esters causing mitochondrial dysfunction and, subsequently, impaired energy metabolism (GA-I, [2, 13, 14] ; MMAuria, [11, 12] ).
Understanding the origin (e.g. liver, kidney or central nervous system [CNS]) of cerebrally accumulating neurotoxic DCAs is essential for designing therapeutic strategies ranging from dietary restriction of precursor amino acids of neurotoxic DCAs and pharmacological activation of the formation of non-toxic acylcarnitines [15] to invasive therapies such as liver or combined liver/kidney transplantation [16] . In GA-I, it has been originally hypothesized that GA and 3-OH-GA [17] are produced in the liver and are transported into the brain via the blood-brain barrier (BBB). However, we have found preliminary evidence that the BBB is only weakly permeable for GA and 3-OH-GA [2] . Due to the fact that GA-I patients and Gcdh-deficient mice display GA and 3-OH-GA concentrations in the brain that exceed plasma levels 10-10,000times [2, 5] , we have hypothesized that GA and 3-OH-GA are de novo synthesized in the CNS and are intracerebrally trapped due to limited efflux (so-called 'trapping hypothesis') [2, 18] . Importantly, the BBB remains intact and is weakly permeable for GA and 3-OH-GA while inducing metabolic crises and striatal injury in Gcdh-deficient mice [19] . For MMAuria, however, nothing is as yet known whether the BBB is involved in the neuropathogenesis.
The blood-cerebrospinal fluid (CSF) barrier (BCB), i.e. the choroid plexus, is the second important metabolic barrier of the brain. Uptake of DCAs at the CSF site of the choroid plexus has previously been described [20] . However, little is known about the role of this barrier in organic acidurias. Although the surface area of the choroid plexus is several thousand times smaller than the surface area of the BBB [21] , transport of toxic DCAs may occur via this route.
Since it is of pathophysiological and therapeutic importance to understand cerebral import and export of GA, 3-OH-GA, and MMA across the BBB and BCB, our study aims to identify transport systems that may mediate this transport. Putative candidates for the transport of DCAs across the BBB are members of the SLC22 (organic acid transporter [OAT] 1-4; [22] ) and SLC13 (Na + -dependent DCA transporter [NaDC] 1-3; [23] ) families that have been shown to transport DCAs in different tissues and cell types. It has been recently postulated that OAT1 and OAT4 mediate the high affinity transport of GA derivatives in proximal tubular kidney cells [24] . Though organic anion transport via OATs at the BBB has been indicated [25] , only expression of OAT3 has as yet been functionally demonstrated at the BBB [26, 27] .
Experimental procedures

RT-PCR
First, we investigated the mRNA expression of candidate DCA transporters by RT-PCR studies in porcine brain capillary endothelial cells (pBCEC). Due to the fact that the porcine genome has not yet been completely sequenced, we used sequence specific primers for cDNAs of the corresponding human (h) protein except for the porcine (ss) OAT3 cDNA that has recently been published. Since the proximal renal tubule has been shown to express OAT1-4 as well as NaDC1 and NaDC3 [28] we used homogenate from proximal tubule of porcine kidney to confirm the specificity of our primers. Total RNA was prepared from pBCEC and proximal tubule cells by RNeasy mini kit (Qiagen). First-strand cDNA was synthesized from 2 μg of RNA using SuperScript III and RNase OUT (Invitrogen) with random hexamer primers. PCR was performed using Failsafe™ PCR-system from Epicentre Biotechnologies (denaturation step, 30 s at 94°C; annealing step, 30 s at 54°C; elongation step, 2 min at 72°C 
Western blotting
To investigate OAT1 and OAT3 protein expression in pBCEC we used polyclonal antibody against the carboxy terminus of these transporters (anti-OAT1, rabbit anti-rat, Alpha Diagnostic, San Antonio, USA, 1:1000, diluted in blocking solution containing 4% [v/v] of nonfat dry milk in Tris-buffered saline Tween-20 (TBST); anti-OAT3, mouse anti-human, Abcam, 1:250 diluted in blocking solution). Cells were washed with prewarmed phosphate-buffered saline and incubated for 10 min with a trypsin solution at 37°C. Afterwards cells were centrifuged at 1000 ×g for 10 min. The cell pellet was washed twice with phosphate-buffered saline and dispensed in RIPA buffer containing 150 mmol/L NaCl, 50 mmol/L Tris-HCl (pH 8.0), 1% NP-40, 0.5% sodium deoxycholate 1 mmol/L sodium vanadate, 5 mmol/L sodium fluoride and 1 mmol/L phenylmethylsulfonyl fluoride. Cells were disrupted using a Becton Dickinson 22 G × 1.25 needle and were incubated on ice for 1 h. To separate solubilized membrane proteins from membrane debris, the homogenate was centrifuged for 10 min at 11,000 ×g at 4°C in an Eppendorf centrifuge. The supernatant was diluted in sodium dodecyl sulfate (SDS) sample buffer (0.5 mol/L Tris-HCl, pH 6.8, 10% glycerol, 1% SDS and 0.01% bromophenol blue). Expression of OAT1 and OAT3 was independently studied. Samples containing 20 μg of protein were applied to a 7.5% gel, separated by SDS-polyacrylamide gel electrophoresis, and then electroblotted to polyvinylidene fluoride membranes which were previously incubated in blocking solution for 1 h to minimize non-specific binding of antibodies. The membrane was then incubated with the primary antibody at 4°C over night. After being rinsed with TBST, membranes were incubated for 2 h with the secondary horse-radish peroxidase-labeled antibody (anti-mouse, anti-rabbit, 1:10,000 diluted in blocking solution, Southern Biotech, Birmingham, USA). After being again rinsed with TBST blots were processed for detection using the Amersham ECL Western Blotting chemiluminescent detection reagents.
Transport of DCAs across cultured pBCEC
Primary cultures of pBCEC were prepared as described previously [2] . Cortical gray matter from fresh porcine brains was minced and digested enzymatically using 0.5% dispase II (Cat. Nr. 04 942 078 001, Hoffmann LaRoche, Mannheim, Germany). Cerebral microvessels were obtained after centrifugation in 15% dextran and were subsequently incubated in a buffer containing 1 mg/mL collagenase/ dispase. The resulting cell suspension was supplemented with 10% horse serum and filtered through 150-μm nylon mesh, and pBCEC were separated on a continuous Percoll™ gradient at concentrations of 1.03 g/mL (20 mL) and 1.07 g/mL (15 mL) (Pharmacia, Uppsala, Sweden). Isolated pBCEC were filtered through a 35-μm nylon mesh before being seeded, at a density of 250,000 cells/cm 2 , onto collagen (Cat. Nr. 11 179 179 001, Roche, Mannheim, Germany)-coated filters in 12-well cell culture plates. Cells were cultivated in Medium 199 containing 100 μg/mL streptomycin, 100 μg/mL penicillin G, 10 mmol/L HEPES, 10% heat-inactivated horse serum, and 0.8 mmol/ L L-glutamine (all from Biochrom, Berlin, Germany). After reaching confluency, medium was changed at 6th day in culture and cells were grown in 45% MEM, 45% F12-HAM, 100 μg/mL streptomycin, 100 μg/ mL penicillin G, 10 mmol/L HEPES, 2 mmol/L L-glutamine (all from Biochrom). At the following day, medium was removed from both compartments of the chamber and cells were washed twice with a Krebs-Ringer buffer (KRB; 115 mmol/L NaCl, 5.9 mmol/L KCl, 1.2 mmol/L MgCl 2 , 1.2 mmol/L NaH 2 PO 4 , 1.2 mmol/L Na 2 SO 4 , 2.5 mmol/L CaCl 2 , 25 mmol/L NaHCO 3 , 10 mmol/L glucose, pH 7.4 and 37°C) and were subsequently used for the transport experiments.
Transport
was characterized with regard to influx (transport into the brain) and efflux (transport out of the brain) and whether it was Na + -and energy-dependent as well as competitively inhibitable by the OAT1 and 3 substrate para-aminohippuric acid (PAH; 4 mmol/L). In Na + -free KRB, Na + was substituted with an equimolar concentration of n-methylglucamine (NMG). To reduce mitochondrial ATP production, NaCN (2 mmol/L) was added to the transport buffer. For fluorescein transport studies, wells were washed twice with KRB. Fluorescein (1 μmol/L in KRB) was added to the same compartment of the chamber as the before tested DCAs without variation of the standard transport conditions, i.e. only in presence of KRB. Cells were incubated for 90 min (37°C) and 200 μL of buffer were removed from the acceptor compartment after 30 min, 60 min, and 90 min. The concentrations of d 4 -GA, d 5 -3-OH-GA, and d 3 -MMA were analyzed by gas chromatography/mass spectrometry. Fluorescein was detected using a Tecan™ fluorometer.
Using the same in vitro system we studied also time dependence of basolateral 14 C-GA (100 μmol/L; specific activity, 0.1 μCi/nmol) uptake and basolateral 14 C-GA uptake in the presence of the OAT1 and 3 substrate estrone sulfate, the OAT3 substrate taurocholate, and the OAT1 and 3 inhibitor probenecid (each 1 mmol/L). After incubation with 14 C-GA cells were washed twice with ice cold KRB, harvested with 0.1 mol/L NaOH and intracellularly trapped 14 C-GA was detected by a scintillation counter (LS6500 Beckman Coulter).
The apparent permeability coefficient (P) was calculated according the following Eq. (1):
∂Q/∂t, Change of concentration of GA, 3-OH-GA or MMA in the acceptor compartment as a function of time; A, surface area of the filter (1.1 cm²); V ac , volume of the acceptor compartment; C 0 , initial concentration of GA, 3-OH-GA or MMA in the donor compartment. 
Multidrug resistance protein 2 (MRP2) assay
GA, 3-OH-GA and MMA were tested for interaction with MRP2 transporter as previously described [29] . Briefly, Caco2 cells overexpressing MRP2 were seeded at a density of 80,000 cells/well in 96-well plates and incubated in DMEM supplemented with 3.7 g/L NaHCO 3 , 4.5 g/L glucose, stable glutamine (2 mmol/L), FCS (10%), penicillin/streptomycin (100 U/mL; 100 μg/mL), non-essential amino acids (1%) and sodium pyruvate (1 mmol/L) (all from Biochrom, Berlin, Germany) for three weeks. Subsequently, cells were washed twice with 37°C warm KRB and incubated simultaneously with 1 μmol/L 5-chloromethylfluorescein-diacetate and testing substances (up to 1 mmol/L in KRB; pH 7.4). The MRP2 inhibitor MK571 (50 μmol/L) was used as positive control. The nonfluorescent, lipophilic fluorescein derivate 5-chloromethylfluorescein-diacetate permeates the cell membrane and is intracellularly cleaved by non-specific esterases into the hydrophilic fluorescent intermediate chloromethylfluorescein. The chloromethyl residues react with the thiol groups of glutathione resulting in the highly hydrophilic fluorescent MRP2 substrate glutathione methylfluorescein. After incubation cells were washed twice with ice cold KRB and lysed with 1% Triton X-100 in KRB. Intracellularly accumulated fluorescence was measured using a Fluoroscan Ascent™ plate reader (ThermoElectron, Dreieich, Germany) with excitation at λ = 485 nm and emission at λ = 520 nm. To exclude false negative results substances were tested for esterase inhibition. Results are given as percentage of fluorescence in the control.
Breast cancer resistance protein (BCRP) assay
The interacting potency of GA, 3-OH-GA and MMA with BCRP efflux activity was studied in pBCEC using mitoxantrone as fluorescent substrate [30] . pBCEC were incubated for 1 h in DMEM/Ham's F12 1:1 (Biochrom, Berlin, Germany) at a density of 2.5 × 10 7 cells/mL.
Afterwards, 600 μL of cell suspension were incubated simultaneously with 15 μmol/L mitoxantrone and test compounds (up to 1 mmol/L in DMEM/Ham's F12; pH 7.4) for 1 h at 37°C. The specific BCRP inhibitor fumitremorgin C (10 μmol/L) was used as positive control. Subsequently, cells were centrifuged at 200 ×g for 5 min and were washed twice with ice cold KRB. Intracellular mitoxantrone fluorescence was measured using a FACS Calibur flow cytometer (Becton Dickinson, Franklin Lakes NJ, USA) equipped with a 635 nm red diode laser and 670 nm bandpass filter. By gating on forward and side scatter, endothelial cells were separated from debris and dead cells were excluded likewise using propidium iodide staining. Twenty thousand cells were sorted in one run. Data were processed and analyzed with CellQuest™ Pro (Becton Dickinson).
P-glycoprotein (P-gp) assay
Modulatory effects on P-gp transport function were examined in pBCEC using calcein-AM as substrate [31] . pBCEC were cultivated as a monolayer as described above and were washed twice with 37°C warm KRB. Afterwards, cells were preincubated with 100 μL of test compound (up to 1 mmol/L in KRB; pH 7.4) for 15 min at 37°C followed by addition of a calcein-AM solution (1 μmol/L) incubation for 30 min. The non-fluorescent lipophilic ester calcein-AM diffuses across the cell membrane but is immediately exported by P-gp. Competitive inhibition of P-gp by the tested DCAs will result in increasing intracellular calcein-AM levels where it is hydrolysed by non-specific esterases into the fluorescent dye calcein. Cells were washed twice with ice cold KRB and intracellular fluorescence was measured after 30 min cell lyses with 1% Triton X-100 using a Fluoroscan Ascent™ plate reader (excitation at λ = 485 nm and emission at λ = 520 nm). The calcium-channel antagonist verapamil (100 μmol/L) was used as positive control.
Organic anion transporting polypeptide (OATP) 1B3 assay
Inhibition of OATP1B3-mediated intracellular uptake of Fluo-3 due to GA, 3-OH-GA or MMA was tested according to Baldes et al. [32] . hCPEC were purchased from Sciencell (Carlsbad, USA) and cultivated in Epicem medium supplemented with 10% heat-inactivated FCS, 100 U/mL penicillin, 0.1 mg/mL streptomycin and a mixture of growth supplements. Cells were grown in poly-L-lysinecoated T75 culture flasks. For transport studies cells were subsequently harvested at a confluence of 70% using accutase and centrifuged for 10 min at 1000 × g. Cells were counted and plated onto poly-L-lysine-coated Transwell filters (60,000 cells per well) at 37°C for 48 h. Uptake of 14 C-GA and time-dependent transport of 14 C-GA across hCPEC was characterized including the investigation of energy and sodium dependency (as described above for pBCEC) as well as its competition with probenecid (2 mmol/L). The apical compartment of the chamber represents the CSF site and the basolateral compartment represents the blood site. Cells were harvested using 100 μL NaOH (0.1 mol/L) per well. 14 C-GA was detected using a scintillation counter (LS6500 Beckman Coulter).
Statistical analysis
All experiments were performed at least in triplicates. If more than three independent experiments have been performed, this is explicitly stated. Data were expressed as mean ± S.D. if not indicated differently. For pairwise and multiple comparisons Student's t test and ANOVA with Bonferroni adjustment respectively were calculated. Time-dependent transport studies with and without the addition of inhibitors were evaluated using ANOVA repeated measures. All statistics were calculated in SPSS for Windows 16.0 Software. p b 0.05 was considered as significant.
Results
RT-PCR and protein expression of putative DCA transporters in pBCEC
The control RT-PCR in homogenate from porcine proximal tubule revealed specific bands for OAT1, OAT3, NaDC1, and NaDC3 with the predicted sizes (Fig. 1a) . RT-PCR studies in pBCEC identified specific products for hOAT1 and ssOAT3 but revealed no PCR products for hNaDC1, hNaDC3, hOAT2, and hOAT4. Whereas the ssOAT1 product (480 bp) had almost the predicted size (517 bp), the ssOAT3 product (1.4 kb) was three times larger than the predicted product (521 bp; Fig. 1b) . The same result was repeated in three independent experiments. Sequence analysis underlined the specificity of the product showing that a 150 bp sequence at the 3′ end and a 105 bp sequence at the 5′ end is 92% and 93% respectively identical to the corresponding porcine cDNA sequence. For a full sequence analysis of the PCR product, it was subcloned in E. coli using a pGEM ® -T-Easy vector system (Promega). The full sequence (1.4 kb) of the PCR product shared a 75% similarity to the human OAT3 mRNA indicating that the protein expressed in pBCEC is a splice variant to the originally published sequence.
In Western blot analysis, the antibody against OAT3 detected a specific band with a molecular mass of approximately 62 kD corresponding to the OAT3 protein [26] . Using an antibody against OAT1 we found a protein product with a molecular mass of approximately 57 kD as previously described ( [33] ; Fig. 1c ).
Characterization of DCA transport in pBCEC
First, we investigated the transport of d 4 -GA, d 5 -3-OH-GA, and d 3 -MMA (each up to 1 mmol/L) from the basolateral compartment of the chamber to the apical compartment (simulating efflux from brain to blood) and vice versa (simulating influx from blood to brain). Efflux of all tested DCAs was significantly higher than their influx ( Fig. 2 ; n = 6 independent experiments, p b 0.05). To describe the efflux transport in further detail all subsequent experiments were carried out as efflux experiments.
We tested whether efflux transport of d 4 -GA, d 5 -3-OH-GA, and d 3 -MMA was dependent on Na + and ATP, and whether it competed with PAH, a known OAT substrate. d 4 -GA, d 5 -3-OH-GA, and d 3 -MMA revealed the same transport characteristics in our experiments. Efflux transport of these DCAs (each 100 μmol/L) was inhibited by PAH (4 mmol/L) and was decreased when Na + was replaced by NMG. In contrast, addition of the cytochrome c oxidase inhibitor NaCN (2 mmol/L) did not influence the efflux of these compounds indicating that it was not energy-dependent (d 4 To refine our findings, we investigated time-dependent basolateral 14 C-GA (100 μmol/L; specific activity, 0.1 μCi/nmol) uptake. 14 C-GA uptake was described by a Michaelis-Menten-like kinetic with the highest import rate within the first 10 min and a reduced but linear transport rate after 20 min (Fig. 4a) . Simultaneously we detected the amount of 14 C-GA that was transported across pBCEC in these experiments. The transport rate was in the same range as shown for d 4 -GA and linear over the whole incubation period (Fig. 4b) . A comparison of cellular uptake and transcellular transport kinetics showed that GA is transported into the cell but accumulates intracellularly due to weak efflux. Next, we studied the basolateral uptake of 14 C-GA (100 μmol/L; specific activity, 0.1 μCi/nmol) in the presence of the OAT1 and 3 substrate estrone sulfate, the OAT1 and 3 inhibitor probenecid, and the OAT3 substrate taurocholate (each 1 mmol/L; incubation time 10 min). Probenecid and estrone sulfate showed a significant cis-inhibitory effect on 14 C-GA uptake (uptake inhibition, 50% and 48% respectively; p b 0.05; Fig. 4c ). The inhibitory effect of taurocholate was less pronounced (uptake inhibition, 26%; p b 0.05; Fig. 4c ).
Transport of fluorescein across pBCEC
To investigate whether DCAs were trapped in pBCEC during transport studies as indicated by the 14 C-GA uptake experiment, we determined the efflux of the OAT1 and 3 substrate and monocarboxylic acid fluorescein across pBCEC immediately after these cells were preconditioned by the above described DCA transport studies. Loading of pBCEC with DCAs will stimulate the uptake of the monocarboxylic acid fluorescein in a concentration-dependent way via anion exchange. Fluorescein (1 μmol/L) transport across pBCEC was monitored for 90 min and was approximately two times higher than the transport of d 4 control). Fluorescein transport was not or only mildly increased in wells with previously inhibited DCA transport, i.e. cis-inhibition with PAH and replacement of Na + with NMG (Fig. 5) . Efflux of fluorescein was also inhibited after preconditioning with NaCN in combination with GA, 3-OH-GA or MMA suggesting that the fluorescein transport is at least partially energy-dependent (Fig. 5) .
DCAs are not transported via MRP2, P-gp, BCRP, and OATP1B3
To exclude that members of the ATP-binding cassette transporter family or the organic anion transporting polypeptide family mediate the transport of d 4 -GA, d 5 -OH-GA, and d 3 -MMA, we performed transport studies with selected members of these transporter families, i.e. MRP2, P-gp, BCRP, and OATP1B3. Specific inhibitors for these transporters -BCRP, fumitremorgin C (10 μmol/L); P-gp, verapamil (100 μmol/L); OATP1B3, bromosulfophthalein (1 μmol/L); MRP2, MK571 (50 μmol/L) -significantly reduced their activity, whereas d 4 -GA, d 5 -OH-GA, and d 3 -MMA (up to 1 mmol/L each) had no effect (Fig. 6 ). This result shows that GA, 3-OH-GA, and MMA are no substrates for the tested ATP-binding cassette transporters and organic anion transporting polypeptide.
Cytotoxicity assay
BBB breakdown reduces or even eliminates the metabolic separation of blood and brain. Therefore we investigated whether 
Characterization of DCA transport in hCPEC
Next we studied the transport of 14 C-GA (100 μmol/L; specific activity, 0.1 μCi/nmol) across hCPEC. DCA transporters (OAT1 and 3; NaDC1 and 3) have been shown to be exclusively expressed at the CSF site of the choroid plexus [20] . In line with this finding, permeation of 14 C-GA from the CSF site to the blood site of the chamber (representing efflux; apparent permeability coefficient: 2.6 × 10 − 5 ± 6.9 × 10 − 6 cm/s) was 4.4 times higher than the reverse transport (representing influx; apparent permeability coefficient: 5.9 × 10 − 6 ± 3.4 × 10 − 6 cm/s). Therefore, we further investigated DCA efflux.
Uptake of 14 C-GA (20 min incubation) at the CSF site was dependent on Na + and was decreased in the presence of the cyclochrome c oxidase inhibitor NaCN (2 mmol/L). The OAT substrate probenecid (2 mmol/L) had no effect on 14 C-GA uptake (Fig. 8a) . Permeation of this DCA across hCPEC was neither inhibitable by probenecid nor dependent on the Na + gradient or on energy (Fig. 8b) suggesting nonspecific permeation.
Discussion
The BBB is a central biochemical interface between the systemic circulation and the CNS gate-keeping the transport of hydroxyphilic compounds to and from the brain. The transport of many drugs and hydrophilic nutrients including monocarboxylic acids and amino acids has been intensively studied (for review, e.g. [34, 35] ). In contrast, little is known about the transport of DCAs across the BBB which is much more limited than those of amino acids and monocarboxylic acids [2, 19, 36] . Accumulation of GA, 3-OH-GA, and MMA is the biochemical hallmark of the inherited organic acidurias GA-I and MMAuria and is involved in their neuropathogenesis. Therefore, we studied the transport of these DCAs across cultivated pBCEC and hCPEC, in vitro models for the mammalian BBB and BCB respectively.
Our study shows that there is a specific transport system for DCAs at the BBB, OAT1 and OAT3, but with a low capacity and that there is virtually no transport of DCAs across the choroid plexus.
Low capacity DCA transport across the BBB via OAT1 and OAT3
Transport of DCAs can be mediated by members of the SLC22 (OAT 1, 3 and 4; [22] ) and SLC13 (NaDC 1 and 3; [23] ) families. OATs couple the import of monocarboxylic acids, such as PAH, to the export of DCAs and, thereby, are energy-independent. The import of monocarboxylic acids via OATs, however, is indirectly coupled to the Na + gradient by NaDCs [37, 38] . NaDCs co-import DCAs and Na + replenishing the intracellular pool of DCAs (tertiary active transport). NaDCs and OATs have been shown to be co-expressed in renal proximal tubular cells [39] and choroid plexus [20] . At the BBB, however, only functional OAT3 has as yet been identified [26, 27] .
Using RT-PCR studies and Western blotting we demonstrated that OAT3 and OAT1 but not NaDCs are expressed in pBCEC. In vitro transport studies in pBCEC demonstrated that efflux transport (CNS to plasma) of GA, 3-OH-GA, and MMA was more pronounced than their influx (plasma to CNS) which was close to the rate of non-specific paracellular permeation. This is in line with previous studies showing that OAT3 is mainly expressed at the CNS site of brain endothelial cells [26, 27] . Consistently with the transport characteristics of OAT1 and OAT3, cellular uptake of GA was cis-inhibited by probenecid, estrone sulfate and, taurocholate. Estrone sulfate and probenecid revealed a stronger cis-inhibitory effect than taurocholate. This finding highlights that OAT1 and 3 are involved in DCA uptake since taurocholate is mainly a substrate of OAT3 whereas probenecid and estrone sulfate are inhibitor and substrate respectively of OAT1 and 3. Efflux transport of GA, 3-OH-GA, and MMA across pBCEC was cis-inhibited by the OAT1 and 3 substrate PAH and was energy-independent. Studying DCA transport in representative members of the ATPbinding cassette transporter family and the organic anion transporting polypeptide family, i.e. MRP2, BCRP, P-gp, and OATP1B3, we did not find evidence that DCAs are substrates of these transporter families. Further, we showed that GA, 3-OH-GA, or MMA are not cytotoxic to pBCEC which would result in increased non-specific paracellular permeation. A breakdown of the BBB integrity has been postulated to play a role in the pathophysiology of GA-I [14, 17] , whereas this mechanism was not confirmed by another study [19] . In line with the latter study, GA, 3-OH-GA, and MMA did not show cytotoxic effect on pBCEC even after one week of incubation at pathophysiologically relevant concentrations. Interestingly, our study demonstrates that transport of GA, 3-OH-GA, and MMA across pBCEC is Na + -dependent. Since we did not find evidence that NaDCs are expressed in pBCEC, we hypothesize that the import of DCAs via OAT1 or OAT3 is also coupled to a system that replenishes the cellular drain of monocarboxylic acids. This monocarboxylic acid transport system remains to be elucidated. A putative candidate is the monocarboxylic acid/proton co-transporter MCT1 which is known to play an important role in the transport of monocarboxylic acids across the BBB [40] . Since Na + -free medium would inhibit Na + /H + exchangers, impair MCT1 transport and, subsequently, reduce the transport of DCAs via OAT1 and 3 due to a lack of suitable exchange molecules, our observation of Na + -dependent transport of DCAs via OAT1 and 3 very well fits to a functional coupling of OAT1 and 3 with MCT1 at the BBB.
Intracellular trapping of DCAs: discrepancies of the apical and basolateral BBB site
Uptake of GA in pBCEC was time-dependent and revealed Michaelis-Menten-like kinetics but with a slow and linear transport phase instead of a plateau. The simultaneously recorded transcellular transport was linear over the time. These findings suggest that GA is effectively imported into the cell, whereas it is only weakly exported causing intracellular accumulation of GA and, subsequently, decrease of cellular GA uptake. Consistent with this notion, fluorescein efflux studies showed increased transport of this monocarboxylic acid when pBCEC were preconditioned with a DCA and unchanged transport when DCA transport had been inhibited by PAH and replacement of Na + by NMG. Interestingly, fluorescein transport across pBCEC was also inhibited after pre-incubation with DCA and NaCN, a condition that did not inhibit DCA transport. This finding demonstrates that at least at one site of the pBCEC a transporter other than OATs mediates fluorescein transport. MRP2 is a likely candidate for alternative fluorescein transport, since glutathione-conjugated fluorescein is a known substrate of MRP2 which is expressed at the apical site of the BBB [41] . Therefore, our data suggest that fluorescein is imported via OAT1 or OAT3, is conjugated to glutathione by the glutathione-Stransferase and is finally exported by MRP2. The transport rate of fluorescein was approximately two times higher than the DCA transport rate providing further evidence that transport across the apical BBB site is the rate limiting step in DCA transport.
DCA transport systems are restricted to the CSF site of choroid plexus
Finally, we studied the transport of 14 C-GA across hCPEC, an in vitro model of the BCB. Our experiments revealed transport characteristics for the uptake of 14 C-GA that are in line with previously published data showing that OAT1 and 3 as well as NaDC1 and 3 are expressed at the CSF site of the choroid plexus [20] . Efflux of this DCA was significantly higher than influx and only uptake at the CSF site revealed specific transport characteristics. The uptake was strongly dependent on the Na + gradient and inhibited by NaCN indicating an involvement of NaDC1 and 3. In contrast, the uptake was not affected by probenecid demonstrating that OATs do not mediate the cellular import of DCAs when NaDCs are co-expressed and functional. Though we also found a permeation of 14 C-GA across hCPEC, it was neither dependent on energy or Na + nor inhibited by probenecid. This finding highlights that there is no active transport of DCAs across hCPEC. In combination with the fact that the BBB surface is several thousand times larger than the surface of the choroid plexus [21] , it is unlikely that neurotoxic DCAs accumulating in MMAuria or GA-I are effectively transported across the choroid plexus. 4.4. Modulation of DCA transport across the BBB: a novel therapeutic option for organic acidurias?
In conclusion, our study indicates that OAT1 and OAT3 participate in the efflux GA, 3-OH-GA, and MMA across the BBB. The low permeability of the BBB for DCAs is likely to be caused by a weak OAT1 and OAT3 expression at the apical site of BCEC. Trans-stimulation of the DCA transport via OAT1 and OAT3 by monocarboxylic acids such as PAH or upregulation of OAT1 and OAT3 at the BBB should be considered as novel therapeutic approach to decrease the intracerebral concentrations of neurotoxic DCAs which are trapped within the brain compartment [2, 18] . Interestingly, dihydrotestosterone has been shown to upregulate OAT3 expression in immortalized rat BCEC via androgen receptor [42] . It should be tested whether this strategy is effective and safe and whether it could be added to current metabolic treatment which aims to reduce the cerebral de novo synthesis of neurotoxic DCAs.
